aTYR PHARMA INC (ATYR) stock
ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$4.99−0.25 (-4.77%)
Close on Nov 17, 2026Market cap $489.46MP/E –Yield –
aTYR PHARMA total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
aTYR PHARMA's total debt was $3.06M at Sep 30, 2020. For fiscal 2019 it was $8.74M, down 45.5% from the year before. The highest annual figure on record is $19.73M in fiscal 2017.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $8.74M | -45.5% |
| FY2018 | Dec 31, 2018 | $16.03M | -18.8% |
| FY2017 | Dec 31, 2017 | $19.73M | +106.9% |
| FY2016 | Dec 31, 2016 | $9.54M | +85.5% |
| FY2015 | Dec 31, 2015 | $5.14M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | $3.06M | -71.1% |
| Q2 FY2020 | Jun 30, 2020 | $4.98M | -59.9% |
| Q1 FY2020 | Mar 31, 2020 | $6.87M | -51.8% |
| Q4 FY2019 | Dec 31, 2019 | $8.74M | -45.5% |
| Q3 FY2019 | Sep 30, 2019 | $10.59M | -40.6% |
| Q2 FY2019 | Jun 30, 2019 | $12.42M | -36.5% |
| Q1 FY2019 | Mar 31, 2019 | $14.23M | -28.8% |
| Q4 FY2018 | Dec 31, 2018 | $16.03M | -18.8% |
| Q3 FY2018 | Sep 30, 2018 | $17.81M | +20.8% |
| Q2 FY2018 | Jun 30, 2018 | $19.57M | +34.2% |
| Q1 FY2018 | Mar 31, 2018 | $19.98M | +108.7% |
| Q4 FY2017 | Dec 31, 2017 | $19.73M | +106.9% |
| Q3 FY2017 | Sep 30, 2017 | $14.75M | – |
| Q2 FY2017 | Jun 30, 2017 | $14.58M | – |
| Q1 FY2017 | Mar 31, 2017 | $9.57M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.54M | – |
See a number that looks wrong?